Article (Scientific journals)
Actualisation 2015 des recommandations américaines et européennes pour le traitement du diabète de type 2
Scheen, André; Paquot, Nicolas
2015In Revue Médicale de Liège, 70 (3), p. 122-128
Peer reviewed
 

Files


Full Text
201503_05.pdf
Publisher postprint (411.41 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
Antidiabetic medications; Guidelines; Hyperglycaemia; Personalized medicine; Type 2 diabetes; Article
Abstract :
[en] The strategy for the management of type 2 diabetes, summarized by a group of experts of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), has been updated early 2015. As in the previous position statement published in 2012, a patientcentered approach is recommended and the choice of the best medication, after failure of metformin monotherapy, should be based on the efficacy and safety profile of each pharmacological class. Besides sulfonylureas, thiazolidinediones (pioglitazone), DPP-4 inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists or basal insulin, another new possibility consists in the addition of an inhibitor of sodium-glucose cotransporters type 2 (gliflozin). Thus, the variety of possible triple therapies is increasing dramatically. Furthermore, when a basal insulin (with or without metformin) is not able to adequately control blood glucose, instead of intensifying insulin therapy (as recommended in 2012), new opportunities are available with the addition of a gliptin, a gliflozin or a GLP-1 receptor agonist in the updated 2015 version. A global integrated approach targeting all risk factors is recommended to reduce cardiovascular complications, with a special emphasis on life-style.
Disciplines :
Endocrinology, metabolism & nutrition
Pharmacy, pharmacology & toxicology
Author, co-author :
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Paquot, Nicolas ;  Université de Liège - ULiège > Département des sciences de la santé publique > Diabétologie, nutrition et maladies métaboliques
Title :
Actualisation 2015 des recommandations américaines et européennes pour le traitement du diabète de type 2
Alternative titles :
[en] Updated 2015 ADA-EASD position statement of management of type 2 diabetes
Publication date :
2015
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Revue Medicale de Liege
Volume :
70
Issue :
3
Pages :
122-128
Peer reviewed :
Peer reviewed
Additional URL :
Available on ORBi :
since 20 November 2017

Statistics


Number of views
936 (3 by ULiège)
Number of downloads
1044 (4 by ULiège)

Scopus citations®
 
25
Scopus citations®
without self-citations
1

Bibliography


Similar publications



Contact ORBi